NATURAL KILLER/T-CELL LYMPHOMA
Clinical trials for NATURAL KILLER/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NATURAL KILLER/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NATURAL KILLER/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame rare lymphoma without heavy side effects
Disease control Recruiting nowThis study is for people with early-stage nasal-type NK/T-cell lymphoma who have not had treatment before. It tests a personalized approach using a PD-1 antibody (a type of immunotherapy) combined with radiation therapy. The goal is to improve disease control while reducing side …
Matched conditions: NATURAL KILLER/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThis Phase 2 trial tests a combination of the drug linperlisib plus three older drugs (cyclophosphamide, prednisone, and thalidomide) in 180 adults with non-Hodgkin lymphoma that has returned or not responded to treatment. The goal is to see how many patients achieve a complete o…
Matched conditions: NATURAL KILLER/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC